Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

CAVΛDIS™ is a Dutch biomedical company active in the field of cardiovascular risk assessment. They develop prognostic tests to identify patients at risk of cardiovascular and disease. The company identified several novel biomarkers predictive for cardiovascular events. It is their goal is to develop clinically meaningful risk stratification tools that will help personalize treatment and achieve better patient outcomes.

Dong Wha Pharm Co., Ltd. engages in the manufacture and sale of pharmaceuticals and medicinal chemicals. Its products include medicines for digestion, skin scars, general cold, gum treatment, high blood pressure, infection, gastrointestinal tract control, and others. The company was founded on September 25, 1897 and is headquartered in Seoul, South Korea.

ENZYCHEM LIFESCIENCES Corp. engages in developing, manufacturing, and distributing pharmaceutical products. Its main products include beta lactam antibiotics, non-beta lactam active pharmaceutical ingredient (APIs), and others. The beta lactam antibiotics include Cefazedone, Cefbuperazone and Ceftizoxime. The non-beta lactam APIs include D-cycloserine and Talniflumate. The company was founded on July 20, 1999 and is headquartered in Jecheon-si, South Korea.

Guangzhou Daan Gene Co., Ltd., established on 1988-08-17, Business scope includes agricultural scientific research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Medical equipment rental;Development of Human Gene Diagnosis and Therapy Technology;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;R&D and application of cell technology;Human stem cell technology development and application;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;General machinery and equipment installation services;Special Equipment Repair;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Professional Design Services;software development;Machinery sales;Mechanical Parts,Parts sales;Engage in investment activities with own funds;Engineering Management Services;Refrigeration,Air Conditioning Equipment Manufacturing;General Equipment Repair;Auto New Car Sales;housing lease;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;pharmaceutical production;Inspection and testing service;Residential interior decoration;Import and export;Securities Investment Consulting;Construction Engineering Construction

Prairie Pharms specializes in small molecule plant extracts. They contain monarda, contain thymoquinone, and act as their own delivery system. They are also involved in the care and testing of monarda clones in the research field.

Suzhou Kaixiang Biotechnology Co., Ltd., established on 2010-12-03, The scope of business includes biological fields and instruments,food additives,Technical development of plant extracts and active ingredients,technology transfer,Technical consulting and related technical services;cosmetic,Chemical raw materials and products(In addition to dangerous goods),Instrument purchase and sale;Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:food business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Shanghai Pulmonary Hospital, a subsidiary of Tongji University, is a Chinese company located in Shanghai that provides medical services.

Evergreen Therapeutics engages in the research and development of clinical drugs in the field of immunity and ophthalmology.

Green + Joint Stock Corp. engages in the manufacture and distribution of pharmaceutical and herbal products. The company was founded in 2016 and is headquartered in Ben Tre, Vietnam.

Beijing Huaketai Biotechnology Co., Ltd., established on 2007-01-15, Business scope includes technology development,technology transfer,technical consulting,Technical Services,Technical testing;Wholesale Class I Medical Devices;Wholesale Class II Medical Devices;product design;Sales of special office equipment and accessories,Special laboratory equipment and accessories,General equipment and accessories,Chemical Products(Free of Hazardous Chemicals);Medical Research;Import and export;Technology Import and Export;Agent import and export;lease commercial premises,office(Shall not be used as premises for tangible market operations);rental medical equipment;Production of in vitro diagnostic reagents for medical devices(Chemiluminescent Kit,Fluorescence Immunochromatography Kit),Clinical Laboratory Equipment;Wholesale Class III Medical Devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policy of the district.)

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX.

Infinitus (China) Co., Ltd., a subsidiary of Lee Kum Kee Group Ltd., is a company headquartered in Guangzhou, China, that develops, manufactures and distributes herbal health products.\nThe company says this about itself: Founded in 1992, Infinitus, a member of LKK Health Products Group, is a modern large-scale company that specializes in R&D, production, sales and services of Chinese herbal health products.

The Pasteur Institute of Lille (French: Institut Pasteur de Lille, Pasteur-Lille, IPL) is a research centre and member of the Pasteur Institute network. It includes 14 research units and 1,150 employees including 626 researchers located in Lille, France. There are also 300 employees located outside the Pasteur site. Its revenues are above €70 million. Several neuroscience start-up companies have emerged from the Pasteur Institute of Lille.

Taiho Pharmaceutical Co., Ltd. is engaged in the research, development, production, distribution, and marketing of pharmaceutical products. The company develops drugs primarily in the area of oncology. It also develops other pharmaceuticals, controlled medical devices, designated quasi-drugs, second-class OTC drugs, designated second-class OTC drugs, and third-class OTC drugs; S-1 for the treatment of gastric cancer; TAS-102 for the treatment of colorectal cancer; and anticancer agents for oncologists, other medical care professionals, and patients. In addition, it engages in the research and development in the areas of oncology,